HTA - 13/109/01

Obinutuzumab in combination with Chlorambucil for previously untreated chronic lymphocytic leukaemia: a critique of the submission from Roche (ID650)

Project title: Obinutuzumab in combination with Chlorambucil for previously untreated chronic lymphocytic leukaemia: a critique of the submission from Roche (ID650)

Call to action: 14/90 Batch 32

Research type: Evidence Synthesis

Chief investigator: Associate Professor Martin Hoyle

Contractor: University of Exeter

Cost: £65,625.00

Started: June 2014 | Status: Project complete

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.